Table 4 |
|||
|
Adverse events potentially related to compression bandages (max. 30 months) |
|||
|
4LB (n = 215) |
SSB (n = 209) |
p-value |
|
|
n (%) |
n (%) |
||
|
|
|||
|
Pressure damage |
15 (7.0) |
13 (6.2) |
0.85 |
|
Skin breakdown |
27 (12.6) |
34 (16.3) |
0.33 |
|
Ulcer deterioration |
27 (12.6) |
32 (15.3) |
0.48 |
|
Infection |
28 (13.0) |
35 (16.7) |
0.34 |
|
New ulcer |
13 (6.0) |
22 (10.5) |
0.11 |
|
Allergy/dermatitis related to bandaging |
15 (7.0) |
14 (6.7) |
1.00 |
|
Allergy/dermatitis related to ointment/cream |
9 (4.2) |
10 (4.8) |
0.82 |
|
Recurrence |
2 (0.9) |
5 (2.4) |
0.28 |
|
Limb compromise |
2 (0.9) |
2 (1.0) |
1.00 |
|
|
|||
|
Total |
138 (64.2) |
167 (80.0) |
|
|
|
|||
|
Harrison et al. BMC Nursing 2011 10:20 doi:10.1186/1472-6955-10-20 |
|||
